Cargando…
An update on TroVax(®) for the treatment of progressive castration-resistant prostate cancer
Prostate cancer is a common human malignancy with few effective therapeutic options for treating advanced castration-resistant disease. The potential therapeutic effectiveness of immunotherapy and vaccines, in particular, has gained popularity based on the identification of prostate-associated antig...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116792/ https://www.ncbi.nlm.nih.gov/pubmed/21691576 http://dx.doi.org/10.2147/OTT.S14271 |